U.S. Biopharmaceutical Third-party Logistics Market Size & Outlook
Related Markets
U.S. biopharmaceutical third-party logistics market highlights
- The U.S. biopharmaceutical third-party logistics market generated a revenue of USD 54,104.6 million in 2024 and is expected to reach USD 81,532.9 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.2% from 2025 to 2030.
- In terms of segment, non-cold chain logistics was the largest revenue generating supplychain in 2024.
- Cold Chain Logistics is the most lucrative supplychain segment registering the fastest growth during the forecast period.
Biopharmaceutical third-party logistics market data book summary
| Market revenue in 2024 | USD 54,104.6 million |
| Market revenue in 2030 | USD 81,532.9 million |
| Growth rate | 7.2% (CAGR from 2025 to 2030) |
| Largest segment | Non-cold chain logistics |
| Fastest growing segment | Cold Chain Logistics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cold Chain Logistics, Non-cold Chain Logistics |
| Key market players worldwide | DHL Group, SF Express, United Parcel Service Inc Class B, AmerisourceBergen Drug Corporation, DB Schenker, Kuehne + Nagel International AG, Kerry Logistics Network Ltd, Agility |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.7% of the global biopharmaceutical third-party logistics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. biopharmaceutical third-party logistics market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 81,532.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical Third-party Logistics Market Scope
Biopharmaceutical Third-party Logistics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Agility | View profile | 10001+ | Singapore, Central Region, Singapore, Asia | http://www.agility.com |
| DB Schenker | View profile | 10001+ | Essen, Nordrhein-Westfalen, Germany, Europe | https://www.dbschenker.com/global |
| SF Express | View profile | 10001+ | Shenzhen, Guangdong, China, Asia | https://www.sf-cityrush.com |
| AmerisourceBergen Drug Corporation | View profile | 11-50 | Kelayres, Pennsylvania, United States, North America | http://www.amerisourcebergendrug.com |
| Kuehne + Nagel International AG | View profile | 93064 | Dorfstrasse 50, P.O. Box 67, Schindellegi, Switzerland, CH-8834 | http://www.kuehne-nagel.com |
| Kerry Logistics Network Ltd | View profile | 33100 | 55 Wing Kei Road, 16th Floor, Kerry Cargo Centre, New Territories, Kwai Chung, Hong Kong, Hong Kong, | https://www.kln.com |
| United Parcel Service Inc Class B | View profile | 500000 | 55 Glenlake Parkway, N.E. Atlanta, Atlanta, GA, United States, 30328 | https://www.ups.com |
| DHL Group | View profile | 594396 | Platz der Deutschen Post, Bonn, NW, Germany, 53250 | http://www.dpdhl.com |
U.S. biopharmaceutical third-party logistics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical third-party logistics market will help companies and investors design strategic landscapes.
Non-cold chain logistics was the largest segment with a revenue share of 83.16% in 2024. Horizon Databook has segmented the U.S. biopharmaceutical third-party logistics market based on cold chain logistics, non-cold chain logistics covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. market held a large share in 2020 due to presence of key third party logistics providers in the country. According to the World Bank, the U.S. had an impressive Logistics Performance Index (LPI) score of 3.89 in 2018. The country also has a robust transportation system.
For instance, according to OECD, 2,969,468 million tonne-km of freight transport took place in the country in 2018. In addition, the U.S. biopharmaceutical sector is characterized by a well-developed R&D infrastructure with broad talent pool, stringent scientific regulatory system, and an advanced environment encouraging investments on novel drug discovery & development.
Reasons to subscribe to U.S. biopharmaceutical third-party logistics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. biopharmaceutical third-party logistics market databook
-
Our clientele includes a mix of biopharmaceutical third-party logistics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. biopharmaceutical third-party logistics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. biopharmaceutical third-party logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. biopharmaceutical third-party logistics market size, by transportation, 2018-2030 (US$M)
U.S. Biopharmaceutical Third-party Logistics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
